SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, ...
This innovative 3D model from MIT decouples fetal shape and motion, enhancing MRI analysis and offering critical insights for ...
SciSparc Ltd. (NASDAQ:SPRC) jumped 45.5% in premarket trading Thursday after announcing a new quantum computing initiative focused on 3D protein modeling. The clinical-stage pharmaceutical company, ...